Skip to main content
. 2013 Jun 5;7(1):15. doi: 10.1186/1479-7364-7-15

Table 2.

Association of MRAS gene with obesity and dyslipidaemia

Variant Controls Cases Univariate analysis
Multivariate analysis
Exp( B ) (95% C.I.) p value Exp( B ) (95% C.I.) p value
Obesity
 
 
 
 
 
 
 rs6782181_GG
0.153
0.397
1.15(1.02–1.29)
0.023*
1.16(1.03–1.30)
0.017*
Hypercholesterolaemia
 
 
 
 
 
 
 rs253662_TT
0.051
0.038
0.73(0.59–0.90)
0.041*
0.74(0.53–1.01)
0.054
 rs6782181_GG
0.015
0.022
1.47(1.07–2.03)
0.018*
1.23(1.02–1.47)
0.019*
Low HDL levels
 
 
 
 
 
 
 rs166195_CT+TT
0.356
0.385
1.14(1.00–1.29)
0.047*
1.00(0.99–1.00)
0.961
 rs253662_CT+TT
0.318
0.344
1.13(0.99–1.29)
0.064
1.16(1.01–1.32)
0.030*
 rs6782181_GG
0.151
0.167
1.13(1.00–1.27)
0.045*
1.15(1.02–1.30)
0.023*
High LDL-cholesterol
 
 
 
 
 
 
 rs253662_T
0.192
0.162
0.82(0.70–0.96)
0.013*
0.82(0.69–0.96)
0.014*
 rs253662_CT+TT
0.336
0.291
0.82(0.67–0.98)
0.028*
0.81(0.68–0.98)
0.030*
 rs6782181_G
0.387
0.356
0.88(0.77–0.99)
0.038*
0.88(0.77–0.99)
0.040*
 rs6782181_AG+GG
0.614
0.564
0.82(0.68–0.97
0.019*
0.81(0.68–0.97)
0.019*
Hypertriglyceridaemia
 
 
 
 
 
 
 rs6782181_G 0.152 0.175 1.19(1.00–1.42) 0.067 1.29(1.01–1.45) 0.043*

The table shows the MRAS variants associated with the disease traits. B, odds ratio; C.I., confidence interval. *p < 0.05.